UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 3)

Iridex Corporation
(Name of Issuer)

Common Stock
(Title of Class of Securities)

462684101
(CUSIP Number)

Scott A. Shuda
402 Railroad Avenue, Suite 201
Danville, California 94526

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

August 31, 2007
(Date of Event which Requires Filing
of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1 (e), Rule 13d-1(f) or Rule 13d-1(g), check the following box [_].

Page 1 of 15


CUSIP No. 462684101

1.		Name of Reporting Person I.R.S. Identification No. of Above Person (Entities Only). BlueLine Capital Partners, L.P.

2.		Check the Appropriate Box If a Member of Group (See Instructions)	(a) [ ] (b) [X]

3.		SEC Use Only

4.		Source of Funds (See Instructions) WC

5.		Check Box If Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)	[_]

6.		Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned By Each Reporting Person With	7.	Sole Voting Power 0

	8.	Shared Voting Power 1,479,297

	9.	Sole Dispositive Power 0

	10.	Shared Dispositive Power 1,479,297

11.		Aggregate Amount Beneficially Owned by Each Reporting Person 2,328,002

12.		Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)	\|_\|

13.		Percent of Class Represented by Amount in Row (11) 23.5%

14.		Type of Reporting Person (See Instructions) PN

Page 2 of 15


CUSIP No. 462684101

1.		Name of Reporting Person I.R.S. Identification No. of Above Person (Entities Only). BlueLine Capital Partners II, L.P.

2.		Check the Appropriate Box If a Member of Group (See Instructions)	(a) [ ] (b) [X]

3.		SEC Use Only

4.		Source of Funds (See Instructions) WC

5.		Check Box If Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)	[_]

6.		Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned By Each Reporting Person With	7.	Sole Voting Power 0

	8.	Shared Voting Power 216,845

	9.	Sole Dispositive Power 0

	10.	Shared Dispositive Power 216,845

11.		Aggregate Amount Beneficially Owned by Each Reporting Person 2,328,002

12.		Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)	\|_\|

13.		Percent of Class Represented by Amount in Row (11) 23.5%

14.		Type of Reporting Person (See Instructions) PN

Page 3 of 15


CUSIP No. 462684101

1.		Name of Reporting Person I.R.S. Identification No. of Above Person (Entities Only). BlueLine Capital Partners III, L.P.

2.		Check the Appropriate Box If a Member of Group (See Instructions)	(a) [ ] (b) [X]

3.		SEC Use Only

4.		Source of Funds (See Instructions) WC

5.		Check Box If Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)	[_]

6.		Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned By Each Reporting Person With	7.	Sole Voting Power 0

	8.	Shared Voting Power 480,000

	9.	Sole Dispositive Power 0

	10.	Shared Dispositive Power 480,000

11.		Aggregate Amount Beneficially Owned by Each Reporting Person 2,328,002

12.		Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)	\|_\|

13.		Percent of Class Represented by Amount in Row (11) 23.5%

14.		Type of Reporting Person (See Instructions) PN

Page 4 of 15


CUSIP No. 462684101

1.		Name of Reporting Person I.R.S. Identification No. of Above Person (Entities Only). BlueLine Catalyst Fund VIII, L.P.

2.		Check the Appropriate Box If a Member of Group (See Instructions)	(a) [ ] (b) [X]

3.		SEC Use Only

4.		Source of Funds (See Instructions) WC

5.		Check Box If Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)	[_]

6.		Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned By Each Reporting Person With	7.	Sole Voting Power 0

	8.	Shared Voting Power 151,860

	9.	Sole Dispositive Power 0

	10.	Shared Dispositive Power 151,860

11.		Aggregate Amount Beneficially Owned by Each Reporting Person 2,328,002

12.		Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)	\|_\|

13.		Percent of Class Represented by Amount in Row (11) 23.5%

14.		Type of Reporting Person (See Instructions) PN

Page 5 of 15


CUSIP No. 462684101

1.		Name of Reporting Person I.R.S. Identification No. of Above Person (Entities Only). BlueLine Partners, L.L.C.

2.		Check the Appropriate Box If a Member of Group (See Instructions)	(a) [ ] (b) [X]

3.		SEC Use Only

4.		Source of Funds (See Instructions) WC

5.		Check Box If Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)	[_]

6.		Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned By Each Reporting Person With	7.	Sole Voting Power 0

	8.	Shared Voting Power 1,848,002

	9.	Sole Dispositive Power 0

	10.	Shared Dispositive Power 1,848,002

11.		Aggregate Amount Beneficially Owned by Each Reporting Person 2,328,002

12.		Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)	\|_\|

13.		Percent of Class Represented by Amount in Row (11) 23.5%

14.		Type of Reporting Person (See Instructions) OO

Page 6 of 15


CUSIP No. 462684101

1.		Name of Reporting Person I.R.S. Identification No. of Above Person (Entities Only). BlueLine Partner II, L.L.C.

2.		Check the Appropriate Box If a Member of Group (See Instructions)	(a) [ ] (b) [X]

3.		SEC Use Only

4.		Source of Funds (See Instructions) WC

5.		Check Box If Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)	[_]

6.		Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned By Each Reporting Person With	7.	Sole Voting Power 0

	8.	Shared Voting Power 480,000

	9.	Sole Dispositive Power 0

	10.	Shared Dispositive Power 480,000

11.		Aggregate Amount Beneficially Owned by Each Reporting Person 2,328,002

12.		Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)	\|_\|

13.		Percent of Class Represented by Amount in Row (11) 23.5%

14.		Type of Reporting Person (See Instructions) OO

Page 7 of 15

Item 1. Security and Issuer

This Amendment No. 3 to Schedule 13D relates to Common Stock (the “Common Stock”) of Iridex Corporation (“Iridex” or the “Company”) with its principal executive offices located at 1212 Terra Bella Avenue, Mountain View, CA 94043.

Item 2. Identity and Background


(a)-(b)			This statement is filed on behalf of BlueLine Capital Partners, LP ("BCP I"),
			BlueLine Capital Partners II, LP ("BCP II"), BlueLine Capital Partners III, LP
			("BCP III"), BlueLine Catalyst Fund VIII, L.P. ("BlueLine Catalyst VIII"),
			BlueLine Partners, L.L.C. ("BLGP I") and BlueLine Partners II, L.L.C. ("BLGP
			II" and, together with BCP I, BCP II, BCP III, BlueLine Catalyst VIII and BLGP
			I, "BlueLine" or the "Reporting Entities"). BLGP I is the sole general partner of
			BCP I, BCP II and BlueLine Catalyst VIII and has an interest in the profits of
			BCP I, BCP II and BlueLine Catalyst VIII. BLGP II is the sole general partner of
			BCP III and has an interest in the profits of BCP III. Scott Shuda and Timothy
			Bacci are each Managing Directors of both BLGP I and BLGP II. Messrs. Bacci
			and Shuda each disclaims beneficial ownership for purposes of Rule 13d-3 under
			the Securities Exchange Act of 1934, as amended (the "Act"). The address of the
			principal business office of each of the Reporting Entities and Messrs. Bacci and
			Shuda is 402 Railroad Avenue, Suite 201, Danville, California 94526.

(c)			Each of BCP I, BCP II, BCP III and BlueLine Catalyst VIII is a private
			investment limited partnership. The principal business of both BLGP I and
			BLGP II is to serve as investment manager to a variety of private investment
			funds, including BCP I, BCP II and BlueLine Catalyst VIII, in the case of BLGP I
			and BCP III in the case of BLGP II, and to control the investing and trading in
			securities of these private investment funds. The principal business of Messrs.
			Bacci and Shuda is to act as Managing Directors of BLGP I and BLGP II.

(d)			None of the Reporting Entities nor Messrs. Bacci and Shuda has, during the last
			five years, been convicted in a criminal proceeding (excluding traffic violations or
			similar misdemeanors).

(e)			None of the Reporting Entities nor Messrs. Bacci and Shuda has, during the last
			five years, been a party to a civil proceeding of a judicial or administrative body
			of competent jurisdiction and as a result of such proceeding was or is subject to a
			judgment, decree or final order enjoining future violations of, or prohibiting or
			mandating activities subject to, federal or state securities laws or finding any
			violation with respect to such laws.

(f)			Each of BCP I, BCP II, BCP III and BlueLine Catalyst VIII is a Delaware limited
			partnership. Each of BLGP I and BLGP II is a Delaware limited liability
			company. Messrs. Bacci and Shuda are each U.S. citizens.

Page 8 of 15

Item 3. Source and Amount of Funds

As of the date hereof, the Reporting Entities may, in the aggregate, be deemed to beneficially own 2,328,002 shares of the Common Stock (the “Shares”). The Shares were purchased by the Reporting Entities (i) in the open market and (ii) via a transaction with the Company dated August 31, 2007.

Item 4. Purpose of the Transaction

No change.

Item 5. Interest in Securities of the Issuer


(a)			As of the date of this Schedule 13D, each of the Reporting Entities may be deemed to own
			2,328,002 shares of Common Stock. These shares represent approximately 23.5% of the shares of
			Common Stock outstanding based on (i) 8,316,749 shares of the Company's Common Stock outstanding as
			reported in the Securities Purchase Agreement dated as of August 31, 2007 among the Company and the
			Reporting Entities plus (ii) 1,600,000 shares Company's Common Stock issuable pursuant to the terms
			of such Securities Purchase Agreement.

			The Reporting Entities are making this single, joint filing because they may be deemed to
			constitute a "group" within the meaning of Section 13(d)(3) of the Act. Each Reporting Entity
			expressly disclaims beneficial ownership of any of the shares of Common Stock other than those
			reported herein as being owned by it.

(b)			As of the date of this Schedule 13D: (i) BCP I beneficially owns 1,479,297 shares of Common
			Stock with which BCP I has shared voting power and shared dispositive power with BLGP I; (i) BCP II
			beneficially owns 216,845 shares of Common Stock with which BCP II has shared voting power and
			shared dispositive power with BLGP I; (iii) BCP III beneficially owns 480,000 shares of Common
			Stock with which BCP III has shared voting power and shared dispositive power with BLGP II; (iv)
			BlueLine Catalyst VIII beneficially owns 151,860 shares of Common Stock with which BlueLine
			Catalyst VIII has shared voting power and shared dispositive power with BLGP I; (v) BLGP I
			beneficially owns 1,848,002 shares of Common Stock with which BLGP I has shared voting power and
			shared dispositive power with BCP I, BCP II and BlueLine Catalyst VIII; and (vi). BLGP II
			beneficially owns 480,000 shares of Common Stock with which BLGP II has shared voting power and
			shared dispositive power with BCP III.

(c)			Information concerning transactions in the Common Stock effected by the Reporting Entities
			during the past sixty days is set forth in Exhibit B hereto and is incorporated by this
			reference.

(d)			No person (other than the Reporting Entities) is known to have the right to receive or the
			power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares.

(e)			Not applicable.

Page 9 of 15

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Pursuant to Rule 13d-1(k) promulgated under the Act, the Reporting Entities have entered into an agreement with respect to the joint filing of this statement, and any amendment or amendments hereto, which is attached hereto as Exhibit A.

Item 7. Materials to be Filed as Exhibits

Exhibit A — Joint Filing Agreement dated September 11, 2007, signed by each of the Reporting Entities in order to confirm that this Schedule 13D is being filed on behalf of each of the Reporting Entities.

Exhibit B — Transactions in the Common Stock by the Reporting Entities during the past 60 days.

Page 10 of 15

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: September 11, 2007

		BlueLine Capital Partners, L.P.
		By: BlueLine Partners, L.L.C. Its: General Partner
		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

		BlueLine Capital Partners II, L.P.
		By: BlueLine Partners, L.L.C. Its: General Partner
		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

		BlueLine Catalyst Fund VIII, L.P. By: BlueLine Partners, L.L.C. Its General Partner

		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

Page 11 of 15

		BlueLine Partners, L.L.C.
		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

		BlueLine Capital Partners III, L.P.
		By: BlueLine Partners II, L.L.C. Its: General Partner
		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

		BlueLine Partners II, L.L.C.

		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

Page 12 of 15

EXHIBIT A

Joint Filing Agreement

The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent it knows or has reason to believe that such information is inaccurate. This Joint Filing Agreement may be executed in any number of counterparts and all of such counterparts taken together shall constitute one and the same instrument.

Date September 11, 2007

		BlueLine Capital Partners, L.P.
		By: BlueLine Partners, L.L.C. Its: General Partner
		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

		BlueLine Capital Partners II, L.P.
		By: BlueLine Partners, L.L.C. Its: General Partner
		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

		BlueLine Catalyst Fund VIII, L.P. By: BlueLine Partners, L.L.C. Its General Partner

		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

Page 13 of 15

		BlueLine Partners, L.L.C.
		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

		BlueLine Capital Partners III, L.P.
		By: BlueLine Partners II, L.L.C. Its: General Partner
		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

		BlueLine Partners II, L.L.C.

		By: /s/ Scott Shuda
		Name: Scott Shuda
		Title: Managing Director

Page 14 of 15

EXHIBIT B

On August 31, 2007, the Reporting Entities identified below entered into a Securities Purchase Agreement with the Company pursuant to which each such Reporting Entity acquired the securities indicated below.

	Number Series A		Number of		Aggregate Unit
Name	Preferred Shares		Warrant Shares		Purchase Price

BlueLine Capital Partners, LP		300,000		360,000	$	3,000,000.00

BlueLine Capital Partners II, LP		50,000		60,000	$	500,000.00

BlueLine Capital Partners III, LP		150,000		180,000	$	1,500,000.00

Page 15 of 15

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549